Correction to: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study (Scientific Reports, (2024), 14, 1, (23556), 10.1038/s41598-024-75293-5)

Özyurt N.Alkan A.Gülbağcı B.Seyyar M.Aşık E.Şahbazlar M.Türker M.Kınıkoğlu O.Yerlikaya T.Dinç G.Aytaç A.Kalkan Z.Ebinç S.Gültürk İ.Keskinkılıç M.İşleyen Z.S.Çağlayan D.Türkel A.Aydın E.Şakalar T.Sekmek S.Yıldırım N.Koçak S.Okutur K.Özveren A.Dursun B.Kitaplı S.Eren O.Ö.Beypınar İ.Hacıbekiroğlu İ.Çabuk D.Karaman E.Acar Ö.Paydaş S.Eryılmaz M.K.Demir B.Oruç Z.Yılmaz M.Biricik F.S.Salim D.K.Tanrıverdi Ö.Doğan M.2025-04-102025-04-102025http://hdl.handle.net/20.500.14701/43565Correction to: Scientific Reportshttps://doi.org/10.1038/s41598-024-75293-5, published online 09 October 2024 The original version of this Article contained an error in the spelling of the author Esra Aşık which was incorrectly given as Esra Aydın. The original Article has been corrected. © The Author(s) 2024.Correction to: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study (Scientific Reports, (2024), 14, 1, (23556), 10.1038/s41598-024-75293-5)Erratum10.1038/s41598-024-80587-9